Translation control by p53.
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
The translation of mRNAs plays a critical role in the regulation of gene expression and therefore, in the regulation of cell proliferation, differentiation and apoptosis. Unrestricted initiation of translation causes malignant transformation and plays a key role in the maintenance and progression of cancers. Translation initiation is regulated by the ternary complex and the eukaryotic initiation factor 4F (eIF4F) complex. The p53 tumor suppressor protein is the most well studied mammalian transcription factor that mediates a variety of anti-proliferative processes. Post-transcriptional mechanisms of gene expression in general and those of translation in particular play a major role in shaping the protein composition of the cell. The p53 protein regulates transcription and controls eIF4F, the ternary complex and the synthesis of ribosomal components, including the down-regulation of rRNA genes. In summary, the induction of p53 regulates protein synthesis and translational control to inhibit cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transient stress leads to induction of p53 which activates DNA repair and leads to quiescence (Vousden and Prives, 2009; Kasteri et al., 2018).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kasteri et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., & Weissman, J. S. (2009) · Science · doi:10.1126/science.1168978 · Cited by 3,853 · cited 1×
“used the polysome profiling technique [58].”
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906 · cited 1×
“The p53 tumor suppressor protein is the most well studied mammalian transcription factor that mediates a variety of anti-proliferative processes [13].”
BackgroundStructural features in eukaryotic mRNAs that modulate the initiation of translation.
Kozak, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54860-2 · Cited by 1,836 · cited 1×
“The inhibitory effects of the ternary complex reduce the expression of oncogenic proteins and increases the expression of tumor-suppressor and pro-apoptotic proteins [8,9].”
Backgroundp53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326 · cited 1×
“Instead, the p53 inhibits mTOR signaling [50] and CK2 protein kinase activity (Figure 3).”
BackgroundProtein kinase CK2: structure, regulation and role in cellular decisions of life and death
LITCHFIELD, D. W. (2003) · Biochemical Journal · doi:10.1042/bj20021469 · Cited by 1,233 · cited 1×
“Protein kinase casein kinase 2 (CK2) belongs to the serine/threonine protein kinase family and consists of two catalytic (alpha and/or alpha’) subunits and two regulatory (beta) subunits [41,42].”
BackgroundHierarchical phosphorylation of the translation inhibitor 4E-BP1
Gingras, A.-C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.912401 · Cited by 883 · cited 1×
“In contrast, 4E-BP hyper-phosphorylation causes disruption of the 4E-BP:eIF4E complex and renders eIF4E available for eIF4F formation, which results in an abrogation of eIF4E-binding activity (Figure 1) [11].”
BackgroundThe Scanning Mechanism of Eukaryotic Translation Initiation
Hinnebusch, A. G. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035802 · Cited by 798 · cited 4×
“The p53-dependent FBL inhibition leads to a high translational fidelity (i.e., nonsense suppression or amino acid misincorporation) and increases the initiation of internal ribosome entry site (IRES)-dependent translation [39].”
BackgroundInfluentialInitiation of Protein Synthesis in Eukaryotic Cells
Pain, V. M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00747.x · Cited by 707
Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin
Takagi, M., Absalon, M. J., McLure, K. G., & Kastan, M. B. (2005) · Cell · doi:10.1016/j.cell.2005.07.034 · Cited by 663 · cited 1×
“Interestingly, in response to DNA damage, the ribosomal protein RPL26 binds to both 5′-UTR and 3′-UTR of p53 mRNA, enhancing p53 translation and leading to p53-dependent and MDM2-independent cell cycle arrest [34,35].”
BackgroundStructures of the human and Drosophila 80S ribosome
Anger, A. M., Armache, J.-P., Berninghausen, O., Habeck, M., Subklewe, M., Wilson, D. N., & Beckmann, R. (2013) · Nature · doi:10.1038/nature12104 · Cited by 628 · cited 1×
“Ribosome biogenesis takes place in the nucleolus [15,16].”
BackgroundBywater, M. J., Poortinga, G., Sanij, E., Hein, N., Peck, A., Cullinane, C., Wall, M., Cluse, L., Drygin, D., Anderes, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.019 · Cited by 563 · cited 1×
“A novel, selective RNA pol I transcription inhibitor, CX-5461 (Cylene Pharmaceuticals/Senhwa Biosciences), promotes cancer-specific activation of p53 and apoptosis in malignant B cells [28], which is an interesting development in the search for new anti-cancer therapies.”
BackgroundMarcel, V., Ghayad, S. E., Belin, S., Therizols, G., Morel, A.-P., Solano-Gonzàlez, E., Vendrell, J. A., Hacot, S., Mertani, H. C., Albaret, M. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.013 · Cited by 358 · cited 1×
“, nonsense suppression or amino acid misincorporation) and increases the initiation of internal ribosome entry site (IRES)-dependent translation [39].”
BackgroundAddiction to protein kinase CK2: A common denominator of diverse cancer cells?
Ruzzene, M., & Pinna, L. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.07.018 · Cited by 352 · cited 2×
“Protein kinase casein kinase 2 (CK2) belongs to the serine/threonine protein kinase family and consists of two catalytic (alpha and/or alpha’) subunits and two regulatory (beta) subunits [41,42].”
BackgroundSignaling Pathways Involved in the Regulation of mRNA Translation
Roux, P. P., & Topisirovic, I. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00070-18 · Cited by 324 · cited 1×
“The post-transcriptional mechanisms of gene expression in general, especially those of translation, play a major role in shaping the protein composition of the cell [14].”
BackgroundGenomic architecture and inheritance of human ribosomal RNA gene clusters
Stults, D. M., Killen, M. W., Pierce, H. H., & Pierce, A. J. (2008) · Genome Research · doi:10.1101/gr.6858507 · Cited by 314
p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest
Ho, J. S. L., Ma, W., Mao, D. Y. L., & Benchimol, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7423-7431.2005 · Cited by 312 · cited 1×
“It has also been reported that p53 is able to activate the transcription of RNA pol I and II through repression of c-Myc expression [27] (Figure 2).”
BackgroundStructure of Eukaryotic RNA Polymerases
Cramer, P., Armache, K.-J., Baumli, S., Benkert, S., Brueckner, F., Buchen, C., Damsma, G. E., Dengl, S., Geiger, S. R., Jasiak, A. J., et al. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.130008 · Cited by 304 · cited 1×
“RNA pol I synthesizes ribosomal RNAs (except for 5S rRNA) [24].”
BackgroundRqc2p and 60 S ribosomal subunits mediate mRNA-independent elongation of nascent chains
Shen, P. S., Park, J., Qin, Y., Li, X., Parsawar, K., Larson, M. H., Cox, J., Cheng, Y., Lambowitz, A. M., Weissman, J. S., et al. (2015) · Science · doi:10.1126/science.1259724 · Cited by 293 · cited 1×
“This complex is responsible for peptide bond formation and quality control of nascent peptides [20].”
BackgroundRepression of RNA Polymerase I Transcription by the Tumor Suppressor p53
Zhai, W., & Comai, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5930-5938.2000 · Cited by 289 · cited 1×
“demonstrated that p53-mediated growth suppression occurred by repressing rRNA gene transcription [26].”
BackgroundThe p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
Meek, D. W., Simon, S., Kikkawa, U., & Eckhart, W. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07524.x · Cited by 277 · cited 11×
“Protein kinase casein kinase 2 (CK2) belongs to the serine/threonine protein kinase family and consists of two catalytic (alpha and/or alpha’) subunits and two regulatory (beta) subunits [41,42].”
BackgroundInfluentialTranslation Elongation and Recoding in Eukaryotes
Dever, T. E., Dinman, J. D., & Green, R. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032649 · Cited by 244 · cited 2×
“Posttranslational hypusine modification of eIF5A by deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH) regulates eIF5A activity [51].”
BackgroundTargeting the nucleolus for cancer intervention
Quin, J. E., Devlin, J. R., Cameron, D., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.009 · Cited by 226
Huang, J.-S., Guh, J.-Y., Chen, H.-C., Hung, W.-C., Lai, Y.-H., & Chuang, L.-Y. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010401)81:1<102::aid-jcb1027>3.0.co;2-y · Cited by 225
Yang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., & Colburn, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3894-3906.2004 · Cited by 199 · cited 1×
“Similarly, the tumor suppressor protein programmed cell death protein 4 regulates the protein translation by preventing eIF4A from interacting with eIF4G, leading to translational suppression [12].”
BackgroundConcerted copy number variation balances ribosomal DNA dosage in human and mouse genomes
Gibbons, J. G., Branco, A. T., Godinho, S. A., Yu, S., & Lemos, B. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416878112 · Cited by 196 · cited 1×
“The ribosomal DNA (rDNA) genes are organized at the nucleolar organizer regions [17,18].”
Backgroundp53 is a general repressor of RNA polymerase III transcription
Cairns, C. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3112 · Cited by 190
Bjornsti, M.-A., & Houghton, P. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.027 · Cited by 181 · cited 1×
“The inhibitory effects of the ternary complex reduce the expression of oncogenic proteins and increases the expression of tumor-suppressor and pro-apoptotic proteins [8,9].”
BackgroundCrystal structure of the 80S yeast ribosome
Jenner, L. B., Melnikov, S. V., de Loubresse, N. G., Shem, A. B., Iskakova, M., Urzhumtsev, A., Meškauskas, A., Dinman, J. D., Yusupova, G. Z., & Yusupov, M. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.07.013 · Cited by 173 · cited 1×
“Ribosome biogenesis takes place in the nucleolus [15,16].”
BackgroundHow Ribosomes Translate Cancer
Sulima, S. O., Hofman, I. J. F., De Keersmaecker, K., & Dinman, J. D. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0550 · Cited by 173
Clotrimazole inhibits cell proliferation in vitro and in vivo
Benzaquen, L. R., Brugnara, C., Byers, H. R., Gattoni-Celli, S., & Halperin, J. A. (1995) · Nature Medicine · doi:10.1038/nm0695-534 · Cited by 166
p53 represses ribosomal gene transcription
Budde, A., & Grummt, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202402 · Cited by 157 · cited 1×
“The p53-mediated RNA pol I transcriptional repression involves p53 interfering with a set of proteins required for the assembly and initiation of transcriptional machinery on the rRNA promoter [25].”
BackgroundA liaison between mTOR signaling, ribosome biogenesis and cancer
Gentilella, A., Kozma, S. C., & Thomas, G. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.02.005 · Cited by 137 · cited 1×
“8S and 28S rRNA) and 47 distinct ribosomal proteins (RPs) [19].”
Backgroundp53-Dependent Translational Control of Senescence and Transformation via 4E-BPs
Petroulakis, E., Parsyan, A. E., Dowling, R. J. O., Bacquer, O. L., Martineau, Y., Bidinosti, M., Larsson, O. S., Alain, T., Rong, L., Mamane, Y., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.025 · Cited by 136 · cited 1×
“These findings indicate that the combined effect of absence of 4E-BPs and p53 loss synergistically enhanced cell proliferation and tumorigenesis, which provides new insights into anticancer drug therapy [47].”
BackgroundChen, J., Guo, K., & Kastan, M. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349274 · Cited by 135 · cited 1×
“Interestingly, in response to DNA damage, the ribosomal protein RPL26 binds to both 5′-UTR and 3′-UTR of p53 mRNA, enhancing p53 translation and leading to p53-dependent and MDM2-independent cell cycle arrest [34,35].”
BackgroundAktas, H., Flückiger, R., Acosta, J. A., Savage, J. M., Palakurthi, S. S., & Halperin, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8280 · Cited by 127
p53 Inhibits RNA Polymerase III-Directed Transcription in a Promoter-Dependent Manner
Chesnokov, I., Chu, W.-M., Botchan, M. R., & Schmid, C. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7084 · Cited by 114
p53 induces transcriptional and translational programs to suppress cell proliferation and growth
Loayza-Puch, F., Drost, J., Rooijers, K., Lopes, R., Elkon, R., & Agami, R. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r32 · Cited by 114 · cited 1×
“The authors conclude that transcriptional regulation mediates cell-cycle arrest, while the global translation inhibition impacts cell growth [60].”
BackgroundIdentification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop
Zhang, X., Wang, W., Wang, H., Wang, M.-H., Xu, W., & Zhang, R. (2013) · Oncogene · doi:10.1038/onc.2012.289 · Cited by 107 · cited 1×
“This subset of nucleolar elements binds to and inhibits the activity of murine double minute 2 (MDM2), resulting in p53-mediated cell cycle arrest and apoptosis [32].”
BackgroundMolecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
Malka-Mahieu, H., Newman, M., Désaubry, L., Robert, C., & Vagner, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2362 · Cited by 105 · cited 2×
“eIF4A stimulates translation of both capped and uncapped mRNAs in vitro [10].”
BackgroundmTORC1 and CK2 coordinate ternary and eIF4F complex assembly
Gandin, V., Masvidal, L., Cargnello, M., Gyenis, L., McLaughlan, S., Cai, Y., Tenkerian, C., Morita, M., Balanathan, P., Jean-Jean, O., et al. (2016) · Nature Communications · doi:10.1038/ncomms11127 · Cited by 103 · cited 2×
“As described above, the role of CK2 and mTORC1 are major regulators of translation [40].”
BackgroundHorton, L. E., Bushell, M., Baus, D., Tilleray, V. J., Clemens, M. J., & Hensold, J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205662 · Cited by 94 · cited 2×
“A 50% reduction of global protein synthesis was determined in vitro utilizing thermosensitive murine erythroleukemic cells carrying wild-type p53 [43].”
BackgroundAssociation of casein kinase II with immunopurified p53.
HERRMANN, C., Kraiss, S., & Montenarh, M. (1991) · PubMed · Cited by 82
Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
Nathan, C. O., Sanders, K., Abreo, F. W., Nassar, R. M., & Glass, J. (2000) · PubMed · Cited by 78
Translational control and the cancer cell response to stress
Robichaud, N., & Sonenberg, N. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.05.007 · Cited by 70
Preukschas, M., Hagel, C., Schulte, A., Riecken, K., Lamszus, K., Sievert, H., Pällmann, N., Bokemeyer, C., Hauber, J., Braig, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043468 · Cited by 65 · cited 1×
“Furthermore, targeting eIF5A results in p53-mediated premature senescence in glioblastoma cell lines [52].”
BackgroundInhibition of Translational Initiation in Eukaryotic Cells by Calcium Ionophore
Brostrom, C. O., Chin, K. V., Wong, W. L., Cade, C., & Brostrom, M. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94235-3 · Cited by 64 · cited 1×
“The eIF2α phosphorylation results in a reduction in the overall rate of translation initiation [4].”
BackgroundRibosomal Protein S27-like, a p53-Inducible Modulator of Cell Fate in Response to Genotoxic Stress
Li, J., Tan, J. Y., Li, Z., Banerjee, B., Yang, X., Chau, J. F. L., Lee, P. L., Hande, M. P., Li, B., & Yu, Q. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1088 · Cited by 64 · cited 1×
“This ultimately leads to p21-mediated cell cycle arrest [36,37].”
Backgroundp53-directed translational control can shape and expand the universe of p53 target genes
Zaccara, S., Tebaldi, T., Pederiva, C., Ciribilli, Y., Bisio, A., & Inga, A. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.79 · Cited by 60 · cited 1×
“The authors identified about 340 genes whose translation is regulated by p53 [59].”
BackgroundStructural insights into eukaryotic ribosomes and the initiation of translation
Voigts-Hoffmann, F., Klinge, S., & Ban, N. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.07.010 · Cited by 60
Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53.
Loging, W., & Reisman, D. (1999) · PubMed · Cited by 58
Wild-type p53 inhibits protein kinase CK2 activity
Schuster, N., G�tz, C., Faust, M., Schneider, E., Prowald, A., Jungbluth, A., & Montenarh, M. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010401)81:1<172::aid-jcb1033>3.0.co;2-o · Cited by 53 · cited 1×
“Conversely, the wild-type p53 interacts with and inhibits CK2 protein kinase activity [57].”
BackgroundStein, T., Crighton, D., Boyle, J. M., Varley, J. M., & White, R. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205372 · Cited by 47
Therapeutic Opportunities in Eukaryotic Translation
Chu, J., & Pelletier, J. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032995 · Cited by 47 · cited 1×
“Translation initiation plays a critical role in the regulation of cell proliferation, differentiation and apoptosis (reviewed in [1]).”
BackgroundConstantinou, C., & Clemens, M. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208648 · Cited by 46 · cited 2×
“p53 inhibits protein synthesis through directly inhibiting the expression of eIF4E [48] and inhibiting the eIF4F complex assembly by enhancing the de-phosphorylation of 4E-BP1 [45].”
BackgroundRegulation of p53 mediated transactivation by the β‐subunit of protein kinase CK2
Schuster, N., Prowald, A., Schneider, E., Scheidtmann, K., & Montenarh, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00273-2 · Cited by 39 · cited 1×
“Furthermore, the regulatory beta subunit of CK2 can interact with p53 and this interaction reduces the DNA binding activity and the transactivation function of p53 [55,56].”
BackgroundRegulation of the DNA binding of p53 by its interaction with protein kinase CK2
Prowald, A., Schuster, N., & Montenarh, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00399-2 · Cited by 36 · cited 1×
“Furthermore, the regulatory beta subunit of CK2 can interact with p53 and this interaction reduces the DNA binding activity and the transactivation function of p53 [55,56].”
BackgroundConstantinou, C., & Clemens, M. J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402045 · Cited by 29 · cited 1×
“Furthermore, p53 activation causes dephosphorylation and cleavage of the initiation factor eIF4GI and the eIF4E-binding protein 4E-BP1 [45,46].”
BackgroundZhao, Y., Tan, M., Liu, X., Xiong, X., & Sun, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0192-3 · Cited by 28 · cited 1×
“This ultimately leads to p21-mediated cell cycle arrest [36,37].”
BackgroundPetersson, J., Ageberg, M., Sandén, C., Olofsson, T., Gullberg, U., & Drott, K. (2012) · Biology of the Cell · doi:10.1111/boc.201100099 · Cited by 20 · cited 1×
“Recent data showed that TRIM22, a p53 target gene, inhibits the binding of eIF4E to eIF4G [44].”
BackgroundShishova, K. V., Khodarovich, Y. M., Lavrentyeva, E. A., & Zatsepina, O. V. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.07.024 · Cited by 17 · cited 1×
“Fibrillarin (FBL) is a nucleolar protein vital for methylation and processing of pre-rRNAs [38].”
BackgroundPKR is not a universal target of tumor suppressor p53 in response to genotoxic stress
Rahman, M., Lem, C., Muaddi, H., & Koromilas, A. E. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9848 · Cited by 5 · cited 1×
“Specifically, Rahman and colleagues showed that p53 is not able to control the ternary complex pathway through PKR-eIF2α activation [49].”
Background
Cited by
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Aging of the cells: Insight into cellular senescence and detection Methods.
Mohamad Kamal, N. S., Safuan, S., Shamsuddin, S., & Foroozandeh, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151108 · Cited by 287
Lipids as Regulators of Cellular Senescence
Hamsanathan, S., & Gurkar, A. U. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.796850 · Cited by 137
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 64
“In this review study, Kasteri et al.(258) investigate the function of p53 as a regulator of the ternary complex, the eIF4F complex, and translation ribosome biogenesis.”
Background40 Years of Research Put p53 in Translation
Marcel, V., Long, F. N. V., & Diaz, J. (2018) · Cancers · doi:10.3390/cancers10050152 · Cited by 62
“The role of p53 in regulating global protein synthesis has been previously reviewed, including one in the present issue [48].”
Background
Metadata
- Authors
- Kasteri, J., Das, D., Zhong, X., Persaud, L., Francis, A., Muharam, H., & Sauane, M.
- Affiliations
- Lehman College (US)
- The Graduate Center, CUNY (US)
- Corresponding author
- Sauane, Moira
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-05-05
- Volume
- 10
- Issue
- 5
- Pages
- 133
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC5977106
- OpenAlex
- W2800089429
- Cited by
- 24
- References
- 62
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion)
- Funders
- National Institutes of Health (SC1 CA2005)
- National Cancer Institute (SC1CA200518, SC1 CA2005)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- p53, translational regulation, mRNA translation initiation, eIF4F, ternary complex, post-transcriptional regulation, ribosomal protein synthesis, tumor suppressor, cell proliferation, apoptosis, cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.